|
HS Code |
262175 |
| Chemical Name | Lactose Monohydrate |
| Molecular Formula | C12H22O11·H2O |
| Molecular Weight | 360.31 g/mol |
| Appearance | White, crystalline powder |
| Solubility In Water | 18.9 g/100 mL (25°C) |
| Melting Point | 202°C (with decomposition) |
| Taste | Slightly sweet |
| Odor | Odorless |
| Ph Value | 5.0–7.0 (10% solution) |
| Cas Number | 64044-51-5 |
| Storage Conditions | Store in a cool, dry place |
| Uses | Pharmaceutical excipient, food additive |
As an accredited Lactose Monohydrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Lactose Monohydrate is packaged in a 25 kg white, food-grade, sealed poly-lined kraft paper bag, clearly labeled for identification. |
| Shipping | Lactose Monohydrate should be shipped in tightly closed containers, protected from moisture and contamination. Store and transport in cool, dry conditions, away from incompatible substances. Follow all local and international regulations for handling food-grade chemicals. Ensure appropriate labeling, and use secondary containment to prevent spills during transit. |
| Storage | Lactose Monohydrate should be stored in a cool, dry, well-ventilated area, away from sources of moisture and incompatible substances. Keep the container tightly closed when not in use, and protect it from direct sunlight. Store at room temperature, typically between 15°C and 25°C. Ensure storage areas are free from pests and contaminants to maintain product quality and safety. |
|
Purity 99.5%: Lactose Monohydrate with 99.5% purity is used in pharmaceutical tablet formulation, where it ensures rapid disintegration and uniform drug distribution. Micronized Particle Size: Lactose Monohydrate micronized particle size is used in dry powder inhaler formulations, where it enhances aerosolization and lung deposition efficiency. Low Moisture Content: Lactose Monohydrate with low moisture content is used in direct compression tablet manufacturing, where it minimizes risk of tablet capping and improves shelf stability. Melting Point 202°C: Lactose Monohydrate of melting point 202°C is used in confectionery coatings, where it provides thermal stability during processing. Bacterial Endotoxin Level <0.25 EU/g: Lactose Monohydrate with bacterial endotoxin level below 0.25 EU/g is used in injectable drug preparations, where it ensures patient safety by reducing pyrogenicity risk. Flowability Grade: Lactose Monohydrate of high flowability grade is used in capsule filling operations, where it increases production throughput and dosage uniformity. Stability Temperature 40°C: Lactose Monohydrate with stability at 40°C is used in high-temperature storage conditions, where it prevents product degradation and maintains consistent performance. Bulk Density 0.7 g/cm³: Lactose Monohydrate with bulk density of 0.7 g/cm³ is used in premix blends for nutraceuticals, where it facilitates homogeneous mixing and accurate dosing. pH 4.5–7.0: Lactose Monohydrate with pH range 4.5–7.0 is used in oral suspension formulations, where it contributes to product palatability and chemical compatibility. |
Competitive Lactose Monohydrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the packed landscape of pharmaceutical and food ingredients, some materials quietly earn decades of trust and confidence. Lactose monohydrate often fits that bill, and anyone who’s spent time in a pharmaceutical lab or food manufacturing plant knows its steady role. Derived from cow’s milk, this simple sugar may not have the glamour of cutting-edge molecules, but it keeps manufacturing processes humming, medicine tablets consistent, and daily products reliable. My own experience in a compounding environment often involved standing next to a large drum of dense, white powder, realizing how recipes old and new lean on this single component to make tablets break right, taste right, and dissolve at the right speed.
Not all lactose powders are created equal, and the differences go far beyond a simple “milk sugar” label. The monohydrate form—meaning each molecule bundles up with a single molecule of water—brings a balance between stability and process performance. Models like the commonly available micronized or milled grades offer a specific range for particle size, frequently listed by suppliers with measurements in microns. These varieties have been refined based on years of real-world trials, input from operators, and strict regulatory demands. In my work, attention to particle size wasn’t just a technical matter; it shaped how a batch handled dust control or mixed cleanly with vitamins, herbal extracts, and other APIs.
This doesn’t just affect the back-of-the-lab workflow. Tablet manufacturers use lactose monohydrate because it binds active substances together smoothly, allowing a tablet press to run without constant stoppages. Compare that to some substitutes—like mannitol, sorbitol, or corn starch—and the downsides start to show. Sorbitol and mannitol, while useful for chewables, often bring extra cost or behave unpredictably with certain drugs. Some alternatives absorb more moisture or cause rushes of stickiness, leaving technicians frustrated and risking batch failure. I’ve watched skilled operators breathe easier when the go-to lactose monohydrate batch behaves just as expected, batch after batch.
Lactose monohydrate serves as more than just a “filler.” In oral medications, it binds active compounds, affecting disintegration and shelf stability. Granulations often use it in combination with binders, lubricants, and disintegrants. One of the most reliable qualities is its gentle sweet taste and neutral odor, two small features that turn out to be critical in masking bitterness and smoothing out flavor profiles in chewable supplements as well as children’s cough remedies.
In food, it lends texture and a faint note of sweetness. Think about the subtle graininess in some protein powders, the smoothness in instant coffee mixes, or even the mild flavor of certain baked goods—lactose monohydrate often plays a part. Lactose-intolerant individuals do need to check labels, but for those who tolerate or process lactose, this compound remains a workhorse. Industry-wide, the switch to lactose-free or plant-based fillers has grown, especially in sports nutrition and vegan supplements. Despite this, lactose monohydrate holds its unique spot, mostly due to unrivaled consistency and a clean regulatory record stretching back generations.
Imagine the production line where tablets roll out by the thousands every minute, each expected to be identical to the last. Between the active pharmaceutical ingredient and the familiar white coating sits lactose monohydrate, holding things together literally and figuratively. Its physical properties, including controlled moisture content, density, and flow behavior, shape the reliability of almost every step—blending, granulation, compacting, and even packaging. Any hiccup here translates into downstream headaches like broken tablets or bottles full of dusted powder.
Working with other excipients, lactose monohydrate’s crystalline structure resists caking and clumping, which means lines move cleanly and operators spend less time clearing blockages. Formulators often come to rely on this predictability, finding that minor adjustments in milling fineness or drying methods can further tailor a blend to specific needs. There’s often talk among seasoned formulators about “the old reliable” or “the trusted filler”—it’s almost always lactose monohydrate.
Anyone standing before a raw material catalog will notice an array of lactose options: lactose anhydrous, spray-dried lactose, and lactose monohydrate, among others. Each form behaves a little differently. The monohydrate brings moisture content to the table—about 5% by weight—setting it apart from the bone-dry anhydrous lactose. That regulated moisture helps certain drugs stay stable, resists excessive dusting, and provides a degree of compactibility that streamlines tablet formation.
Model grades such as lactose monohydrate Type 200 or 100 mesh clarify how refined the particles appear. In real-world use, finer grades work best for direct compression; coarser grades suit wet granulation. Over my years assisting in formulation pilot projects, recipes straying from preferred mesh and moistures always needed more fuss and rework. Some products target rapid dissolution and look for higher surface area, but the sturdy balance of lactose monohydrate consistently fits well into most baseline needs.
There’s no shortage of talk about the “next big excipient” in pharmaceutical circles. Corn starch, microcrystalline cellulose, and newer polyol blends all compete for a piece of the filler market. In my experience, though, lactose monohydrate often edges out these alternatives on cost, compatibility, and ease with regulatory requirements. Starch often tends to swell or clump, causing unpredictable flow through tablet presses. Cellulose binds well but can make tablets less pleasant to chew, while some sugar alcohols like mannitol can cost significantly more and react oddly with certain API substances.
It’s not just the machinery or recipe changes that matter. Consistent supply and long regulatory history mean audits and approval processes stay smoother. When manufacturing hundreds of thousands of doses per day, glitches linked to raw materials can snowball quickly, impacting down-the-line tasks like quality assurance, batch release, and logistics.
One reason for the steady use of lactose monohydrate in pharmaceutical and food products lies in its traceability. Sourced from rigorously inspected milk, refined through industry-recognized methods, and tested at every step, lactose monohydrate checks the boxes for purity and safety. Over time, the standards set for this ingredient have only grown more demanding. Hospitals, manufacturers, and end users alike depend on the trace documentation that trails behind every lot number and certificate of analysis.
Quality assurance matters especially in a world where recalls grab headlines and consumer trust wavers. From my own vantage point, every successful audit or inspection came down to a handful of reliable supplier ingredients—the proven grade of lactose monohydrate always stood out. Companies invest heavily in supplier relationships, not just for price, but for certainty in compliance. Tracking back a batch of lactose monohydrate reveals layers of quality management, environmental monitoring, and documentation built up over decades.
Regulatory landscapes have shifted in recent years, but lactose monohydrate sails forward with confidence built on data and repeated scrutiny. Whether in accordance with United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), or Japan’s J.P. standards, approved pharmaceutical-grade lactose monohydrate grades must meet rigid purity settings—often 99% lactose with trace amounts of protein, ash, and moisture falling within fine-tuned limits. This removes unpredictable variables from manufacturing and streamlines approval for new product launches or novel dosage forms.
Where local regulations require allergen labeling, producers follow through with declaration and proper warning for those with sensitivities. This openness helps build trust. Warnings about lactose intolerance, even for minor uses in excipients, continue to shape how companies design their labeling and marketing strategies. In all of these steps, lactose monohydrate stays in the conversation as a tried-and-true choice that very rarely introduces unpleasant surprises.
Not every ingredient offers the predictability required in day-to-day production. My hands-on experience preparing both small pilot batches and scaled-up commercial lots made me appreciate ingredients that simplify the operator’s work. Lactose monohydrate pours easily from bags without sending dust plumes through the air. It resists caking in humid settings, while some starch-based fillers transformed storage bins into solid blocks overnight. Cleaning up at the end of a shift went that much quicker, thanks to its predictability when exposed to cleaning solvents or water.
Analytical testing reveals little in the way of unanticipated contaminants so long as sources are reputable. Even high-volume manufacturing, with constant sampling, in-process checks, and final QC, rarely stumbles on out-of-spec batches. Operators know what to expect, supervisors sign off with confidence, and pharmacists trust the tablets that reach hospital wards. It’s hard to overstate the relief this brings to everyone up and down the manufacturing chain.
These days, new demands test old standbys more than ever. Food and supplement brands face growing pressure to move away from animal-derived materials, and patient groups often ask about vegan or lactose-free formulations. Some countries see tighter restrictions on dairy-based ingredients or introduce tougher standards for cross-contamination. In these markets, plant-sourced or synthetic alternatives edge their way forward.
Still, lactose monohydrate continues to show surprising resilience. Advanced manufacturing methods now offer “ultra-pure” and “low endotoxin” variants, specialized for sensitive populations or high-stakes medications. The same crystallization technique that set it apart generations ago now supports newer technologies such as 3D-printed tablets and novel dosage systems. Engineers refine spray-drying, sieving, and crystallization to push boundaries of both purity and fineness. In my own practice, I’ve seen R&D teams working side-by-side with suppliers to bend lactose monohydrate to new demands. The cycle of innovation doesn’t spare even the most familiar ingredients.
Pharmacists stocking shelves in major hospitals count on lactose monohydrate’s track record to ensure medicine cabinets stay filled with predictable, safe treatments. At the other end, supplement start-ups may lean toward plant-based trends but admit that consumer feedback often drives them back to tried-and-true blends. Having spent time advising both established generic drug companies and aspirational startups, I notice that many eventually return to lactose monohydrate if performance, cost, and supply security matter more than cutting-edge trends.
Not everything about lactose monohydrate’s reign comes down to habit. It’s the comfort of consistency that shaped confidence in its role. I recall a project reworking a pediatric chewable—caregivers worried about artificial sweeteners and newfangled binders. Going back to a lactose monohydrate base smoothed opinions and restored trust, especially when pediatricians recognized the pedigree behind the formulation. Quality, like reputation, builds up slowly but fades quickly if something goes wrong.
One growing pressure points at sustainability. Milk-derived ingredients always carry a carbon footprint that prompts food and pharma firms to rethink sourcing. Some lactose monohydrate suppliers dip into green energy and better animal husbandry; others support traceability all the way to specific co-ops or dairies. Brands that once quietly sourced from the lowest bidder now pitch their environmental credentials alongside technical specs, knowing conscious consumers care about sourcing and supply chains.
Technologists are not sitting still. Pilot projects sometimes explore plant-derived “lactose analogues,” engineered to mimic the performance of milk-based lactose without the animal link. While interesting, cost and large-scale reliability remain pain points. Even as science creates these new options, it’s impossible to write off lactose monohydrate as a relic. Its ability to meet unyielding pharmaceutical standards, offer predictable behavior at massive scale, and keep costs manageable keeps it near the top of ingredient lists.
Ingredient markets rarely sleep, and today’s “safe bet” never stays immune from change. Those who have worked with lactose monohydrate know its strengths but don’t ignore new consumer voices. I’ve watched buyers pour over ingredient declarations for both allergy management and ethical sourcing. Manufacturers increasingly share their supply chain audits and environmental actions because trust now lives in transparency as much as in technical specs.
Even as the world shifts toward personalized medicine, tailored diets, and ethical manufacturing, lactose monohydrate’s story speaks to the broader value of reliability, transparency, and adaptation. In every lab, factory, and pharmacy I’ve visited, every successful batch relied on a handful of understated ingredients doing the quiet work behind the scenes. Lactose monohydrate stands among those. Its familiar profile blends history, research, and customer insight, linking today’s new ideas with standards that have stood the test of time.
Lactose monohydrate doesn’t need to chase every new trend or promise breakthrough performance on its own. Its strengths spring from a proven record, tight quality controls, and a willingness to evolve—whether that's with finer grades, cleaner manufacturing, or a sharper focus on environmental footprint. Decision-makers in pharmaceuticals, food, and nutraceuticals rarely pick ingredients lightly, but again and again, this simple milk-derived sugar wins a place on the bill of materials. Over an entire career spent among formulas, formulas, and focus groups, I’ve seen the value that steadiness brings. In both my hands and the hands of new technicians, lactose monohydrate continues to deliver not just ingredients, but also the confidence to innovate.